U.S. Markets open in 6 hrs 35 mins

Xtandi: A Key Oncology Pillar in 2019

Margaret Patrick
Xtandi: A Key Oncology Pillar in 2019

Pfizer or AstraZeneca: Which Is a Better Pick in April?(Continued from Prior Part)Xtandi’s growth trends According to Pfizer’s (PFE) fourth-quarter earnings conference call, Xtandi is a pillar of the company’s oncology business. In 2018, Pfizer